Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial U Leiter, R Stadler, C Mauch, W Hohenberger, N Brockmeyer, C Berking, ... The Lancet Oncology 17 (6), 757-767, 2016 | 745 | 2016 |
Epidemiology of skin cancer: update 2019 U Leiter, U Keim, C Garbe Sunlight, Vitamin D and Skin Cancer, 123-139, 2020 | 331 | 2020 |
Incidence, mortality, and trends of nonmelanoma skin cancer in Germany U Leiter, U Keim, T Eigentler, A Katalinic, B Holleczek, P Martus, C Garbe Journal of Investigative Dermatology 137 (9), 1860-1867, 2017 | 222 | 2017 |
Final analysis of DeCOG-SLT trial: no survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node U Leiter, R Stadler, C Mauch, W Hohenberger, NH Brockmeyer, C Berking, ... Journal of Clinical Oncology 37 (32), 3000-3008, 2019 | 214 | 2019 |
Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma–results of a prospective biomarker study A Forschner, F Battke, D Hadaschik, M Schulze, S Weißgraeber, CT Han, ... Journal for Immunotherapy of Cancer 7, 1-15, 2019 | 155 | 2019 |
Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients Y Teramoto, U Keim, A Gesierich, G Schuler, E Fiedler, T Tüting, C Ulrich, ... British Journal of Dermatology 178 (2), 443-451, 2018 | 115 | 2018 |
Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943–2036 C Garbe, U Keim, S Gandini, T Amaral, A Katalinic, B Hollezcek, P Martus, ... European Journal of Cancer 152, 18-25, 2021 | 75 | 2021 |
Time trends in incidence and mortality of cutaneous melanoma in Germany C Garbe, U Keim, TK Eigentler, T Amaral, A Katalinic, B Holleczek, ... Journal of the European Academy of Dermatology and Venereology 33 (7), 1272-1280, 2019 | 70 | 2019 |
Improvement of overall survival in stage IV melanoma patients during 2011–2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR) A Forschner, F Eichner, T Amaral, U Keim, C Garbe, TK Eigentler Journal of cancer research and clinical oncology 143, 533-540, 2017 | 58 | 2017 |
Prognosis of patients with stage III melanoma according to American Joint Committee on Cancer Version 8: a reassessment on the basis of 3 independent stage III melanoma cohorts C Garbe, U Keim, S Suciu, T Amaral, TK Eigentler, A Gesierich, ... Journal of Clinical Oncology 38 (22), 2543-2551, 2020 | 57 | 2020 |
Prognosis of patients with primary melanoma stage I and II according to American Joint Committee on Cancer Version 8 validated in two independent cohorts: implications for … C Garbe, U Keim, T Amaral, C Berking, TK Eigentler, L Flatz, A Gesierich, ... Journal of Clinical Oncology 40 (32), 3741-3749, 2022 | 56 | 2022 |
Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients U Leiter, C Loquai, L Reinhardt, D Rafei-Shamsabadi, R Gutzmer, ... Journal for immunotherapy of cancer 8 (2), 2020 | 50 | 2020 |
Distinct clinicopathological and prognostic features of thin nodular primary melanomas: an international study from 17 centers C Dessinioti, N Dimou, AC Geller, A Stergiopoulou, S Lo, U Keim, ... JNCI: Journal of the National Cancer Institute 111 (12), 1314-1322, 2019 | 38 | 2019 |
Survival of SLNB-positive melanoma patients with and without complete lymph node dissection: A multicenter, randomized DECOG trial. U Leiter, R Stadler, C Mauch, W Hohenberger, N Brockmeyer, C Berking, ... Journal of Clinical Oncology 33 (15_suppl), LBA9002-LBA9002, 2015 | 38 | 2015 |
Diffuse PRAME expression is highly specific for thin melanomas in the distinction from severely dysplastic nevi but does not distinguish metastasizing from non-metastasizing … M Gassenmaier, M Hahn, G Metzler, J Bauer, AS Yazdi, U Keim, C Garbe, ... Cancers 13 (15), 3864, 2021 | 36 | 2021 |
Serial or parallel metastasis of cutaneous melanoma? A study of the German central malignant melanoma registry M Gassenmaier, TK Eigentler, U Keim, M Goebeler, E Fiedler, G Schuler, ... Journal of Investigative Dermatology 137 (12), 2570-2577, 2017 | 34 | 2017 |
Sentinel lymph node dissection in head and neck melanoma has prognostic impact on disease-free and overall survival U Leiter, TK Eigentler, HM Häfner, M Krimmel, U Uslu, U Keim, B Weide, ... Annals of surgical oncology 22, 4073-4080, 2015 | 34 | 2015 |
Effectiveness of carboplatin and paclitaxel as first-and second-line treatment in 61 patients with metastatic melanoma A Pflugfelder, TK Eigentler, U Keim, B Weide, U Leiter, K Ikenberg, ... PloS one 6 (2), e16882, 2011 | 34 | 2011 |
Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasis T Amaral, I Tampouri, T Eigentler, U Keim, B Klumpp, V Heinrich, D Zips, ... Immunotherapy 11 (4), 297-309, 2019 | 33 | 2019 |
Primary resistance to PD-1-based immunotherapy—a study in 319 patients with stage IV melanoma T Amaral, O Seeber, E Mersi, S Sanchez, I Thomas, A Meiwes, ... Cancers 12 (4), 1027, 2020 | 30 | 2020 |